Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open label, multicenter clinical trial to compare the efficacy and
safety of Velcade (bortezomib) and dexamethasone versus Velcade, thalidomide, and
dexamethasone versus Velcade, melphalan, and prednisone in patients with previously untreated
multiple myeloma not considered candidates for high-dose chemotherapy and autologous stem
cell transplantation.